Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
284 participants
OBSERVATIONAL
2025-01-09
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Consistency assessment between AI evaluation scores and human expert evaluation scores for surgeons during left anterior descending (LAD) artery anastomosis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of AI Assisted Follow-up Strategy on Secondary Prevention in CABG Patients
NCT04636996
Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention
NCT02430012
Impact of Body Weight on Outcomes of Patients Undergoing Coronary Artery Bypass Grafting
NCT06614023
Comparison of Post-operation Cardiopulmonary Capacity of Patients Underwent Conventional and Robot-assisted Coronary Artery Bypass Graft and Valve Replacement Surgery
NCT05430568
"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
NCT06615609
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing internal mammary artery-to-left anterior descending artery bypass grafting
* First-time recipient of isolated CABG surgery
* Signed written informed consent
Exclusion Criteria
* Patients with contraindications to coronary CT angiography or coronary angiography
* Patients with renal insufficiency or active liver disease, including those with persistently elevated serum transaminases of unknown cause or any serum transaminase levels exceeding three times the upper limit of normal.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China National Center for Cardiovascular Diseases
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shengshou Hu
Academician of Chinese Academy of Engineering President, Fuwai Hospital Director, National Center for Cardiovascular Diseases Director, NCRC Director, State Key Laboratory of Cardiovascular Disease Chairman, China Heart Congress (CHC) Former President
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fuwai Hospital, CAMS & PUMC
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-ZX070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.